Next-Generation Japanese GLP-1 weight loss pills: Seeking North American Distributors 

Asa Pharmaceutical Co., Ltd. (Head Office: Minato-ku, Tokyo; CEO: Tomoko Iwase), a manufacturer and distributor of health foods, has launched North American expansion of a next-generation diet supplement utilizing proprietary carbonated granule technology, targeting the rapidly growing global “GLP-1 (appetite-suppressing hormone)” support market. In conjunction with this launch, the company has formally begun inviting applications from strategic partners (distributors), including clinics, fitness chains, and luxury spas.

In the United States, GLP-1 receptor agonists such as Mounjaro have attracted significant attention. However, challenges remain, including high costs, resistance to injections, and concerns regarding side effects.

The product offered by Asa Pharmaceutical Co., Ltd. adopts the functional ingredient “Metaboloid (lemon verbena + hibiscus),” which is supported by scientific evidence and promotes natural GLP-1 secretion. In addition, by combining Japan-originated carbonated granule technology with aroma effects, the supplement enables sustainable weight management without excessive burden.

Four Added Values for U.S. Distribution Partners

1. Clinically Supported Evidence for Promoting GLP-1 Secretion
Formulated with “Metaboloid,” recognized as the most innovative ingredient at the NutraIngredients Award in Europe. Clinical trials confirmed increased GLP-1 secretion after intake and a 64% improvement in appetite suppression scores. The product can be presented with confidence to evidence-oriented, high-income consumers in the United States.

2. Carbonated Granule Technology Delivering Visual and Sensory Satiety
The unique texture of carbonated granules that effervesce in the mouth provides not only a refreshing sensation but also expands in the stomach to deliver early physical fullness. By creating a tangible “eating experience,” the supplement helps reduce stress associated with dietary restrictions.

3. Appetite Control Through Mint Aroma
Based on research conducted at Wheeling University in the United States, a mint aroma expected to support appetite suppression is incorporated. The combination of functional ingredients, the physical effects of carbonation, and the psychological effects of aroma establishes a triple-approach differentiation strategy.

4. Backed by Leading Academia
Product development is supervised by a professor specializing in immunology and drug discovery, supporting brand credibility. The MAF Brand conducts extensive research on the relationship between gut environment, neural networks, and overall health (the gut-brain axis), and this expertise is reflected in the product.

Strong Business Support for Distributors
Immediate Entry into a High-Growth Market:
Participation in the GLP-1 trend, which has become a social phenomenon in the United States, is possible in the form of a safe and affordable food product.

Provision of Marketing Materials:
Clinical trial data, mechanism-of-action visuals, and ingredient evidence materials are provided to support sales activities.

Assured Japanese Quality:
Free from artificial sweeteners and synthetic colorants. Manufactured in Japan under strict quality control standards.

Comment from CEO Tomoko Iwase
“We aim to provide products that support the body’s inherent regulatory functions without excessive reliance on pharmaceuticals. This supplement, which integrates Japan’s precise formulation technology with world-class immunological research, is expected to establish a new benchmark in the U.S. wellness market.”


Company Overview

Company Name: Asa Pharmaceutical Co., Ltd.
Location: Minato-ku, Tokyo
Representative: Tomoko Iwase, CEO
Business Description: Manufacture and sale of supplements; development and sale of various cosmetics
Official Website: https://asapharma.jp/